Publication | Closed Access

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryMedicineRheumatic DiseasesRandomised Phase 3ImmunologyClinical TrialsPharmacologyNecrosis Factor InhibitorsInflammatory Rheumatic DiseasePharmacotherapyActive Rheumatoid ArthritisPsoriatic ArthritisRheumatoid Arthritis